Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia

Benzopyran selective estrogen receptor beta agonist-1 (SERBA-1) shows potent, selective binding and agonist function in estrogen receptor β (ERβ) in vitro assays. X-ray crystal structures of SERBA-1 in ERα and β help explain observed β-selectivity of this ligand. SERBA-1 in vivo demonstrates involut...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 49; no. 21; pp. 6155 - 6157
Main Authors Norman, Bryan H, Dodge, Jeffrey A, Richardson, Timothy I, Borromeo, Peter S, Lugar, Charles W, Jones, Scott A, Chen, Keyue, Wang, Yong, Durst, Gregory L, Barr, Robert J, Montrose-Rafizadeh, Chahrzad, Osborne, Harold E, Amos, Robert M, Guo, Sherry, Boodhoo, Amechand, Krishnan, Venkatesh
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 19.10.2006
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Benzopyran selective estrogen receptor beta agonist-1 (SERBA-1) shows potent, selective binding and agonist function in estrogen receptor β (ERβ) in vitro assays. X-ray crystal structures of SERBA-1 in ERα and β help explain observed β-selectivity of this ligand. SERBA-1 in vivo demonstrates involution of the ventral prostate in CD-1 mice (ERβ effect), while having no effect on gonadal hormone levels (ERα effect) at 10× the efficacious dose, consistent with in vitro properties of this molecule.
Bibliography:ark:/67375/TPS-RT0DB63V-K
istex:2EDDB7D4C67C9207C7390ECA03C703232185EB1D
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm060491j